{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T17:02:26Z","timestamp":1780419746794,"version":"3.54.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007051","name":"Uppsala University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007051","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Mast cells are emerging players in malignant conditions, but the underlying molecular mechanisms remain poorly defined. Based on previous studies showing that steroids can impact on tumour progression in various settings, we here investigated whether mast cell-derived steroid synthesis can have an impact on tumour metastasis in a melanoma model. To this end, we used mice with mast cell-specific ablation of Cyp11a1, a key enzyme in steroid synthesis. We show that lung colonization of melanoma nodules was markedly diminished in mice with mast cell-specific ablation of\n                    <jats:italic>Cyp11a1<\/jats:italic>\n                    , accompanied by reduced infiltration of mast cells into the lungs.\n                    <jats:italic>Cyp11a1<\/jats:italic>\n                    gene expression was significantly decreased in lungs of mice with mast cell-specific ablation of Cyp11a1, indicating that mast cells account for a substantial fraction of the total Cyp11a1 expression. Our results also revealed that the mast cell-specific deletion of\n                    <jats:italic>Cyp11a1<\/jats:italic>\n                    led to an overall increase in CD107a\/LAMP1 staining intensity of the lung tissue, suggesting that mast cell-derived steroids can suppress immune cell activation and degranulation. A further dissection of this finding by flow cytometry analysis of individual immune cell populations revealed that CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cells, NK cells and basophils were activated to a higher extent in lungs from mice with mast cell-specific\n                    <jats:italic>Cyp11a1<\/jats:italic>\n                    ablation. We also observe that both CD8\n                    <jats:sup>+<\/jats:sup>\n                    and CD4\n                    <jats:sup>+<\/jats:sup>\n                    T cells in lungs of mice with mast cell-specific deletion of\n                    <jats:italic>Cyp11a1<\/jats:italic>\n                    expressed elevated levels of IFN-\u03b3 in comparison with controls. Altogether, these findings introduce a hitherto unrecognized role of a mast cell-derived steroid axis in regulating tumour metastasis.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-56344-5","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T14:25:10Z","timestamp":1780410310000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mast cell specific Cyp11a1 deficiency promotes T cell mediated immunity and suppresses tumour metastasis in a mouse model of melanoma"],"prefix":"10.1038","volume":"16","author":[{"given":"Md. Abdul","family":"Alim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Butcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"issue":"5","key":"56344_CR1","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/nm.2755","volume":"18","author":"SJ Galli","year":"2012","unstructured":"Galli, S. J. & Tsai, M. IgE and mast cells in allergic disease. Nat. Med. 18 (5), 693\u2013704 (2012).","journal-title":"Nat. Med."},{"issue":"1","key":"56344_CR2","doi-asserted-by":"publisher","first-page":"188845","DOI":"10.1016\/j.bbcan.2022.188845","volume":"1878","author":"S Shi","year":"2023","unstructured":"Shi, S. et al. Focus on mast cells in the tumor microenvironment: Current knowledge and future directions. Biochim. Biophys. Acta Rev. Cancer. 1878 (1), 188845 (2023).","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"11","key":"56344_CR3","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1158\/1078-0432.CCR-24-0246","volume":"30","author":"M Panagi","year":"2024","unstructured":"Panagi, M. et al. Stabilizing Tumor-Resident Mast Cells Restores T-Cell Infiltration and Sensitizes Sarcomas to PD-L1 Inhibition. Clin. Cancer Res. 30 (11), 2582\u20132597 (2024).","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"56344_CR4","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1038\/s41423-020-0421-z","volume":"18","author":"MA Alim","year":"2021","unstructured":"Alim, M. A. et al. Glutamate triggers the expression of functional ionotropic and metabotropic glutamate receptors in mast cells. Cell. Mol. Immunol. 18 (10), 2383\u20132392 (2021).","journal-title":"Cell. Mol. Immunol."},{"key":"56344_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/cells9051134","author":"MA Alim","year":"2020","unstructured":"Alim, M. A., Peterson, M. & Pejler, G. Do mast cells have a role in tendon healing and inflammation?. Cells https:\/\/doi.org\/10.3390\/cells9051134 (2020).","journal-title":"Cells"},{"issue":"5","key":"56344_CR6","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1007\/s10753-024-02011-8","volume":"47","author":"M Grujic","year":"2024","unstructured":"Grujic, M. et al. Mast Cells are Dependent on Glucose Transporter 1 (GLUT1) and GLUT3 for IgE-mediated Activation. Inflammation 47 (5), 1820\u20131836 (2024).","journal-title":"Inflammation"},{"issue":"5","key":"56344_CR7","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1089\/thy.2000.10.381","volume":"10","author":"S Toda","year":"2000","unstructured":"Toda, S. et al. Growth factor-expressing mast cells accumulate at the thyroid tissue-regenerative site of subacute thyroiditis. Thyroid 10 (5), 381\u2013386 (2000).","journal-title":"Thyroid"},{"issue":"5","key":"56344_CR8","first-page":"404","volume":"109","author":"Y Cheng","year":"2017","unstructured":"Cheng, Y. et al. Large Accumulation of Collagen and Increased Activation of Mast Cells in Hearts of Mice with Hyperlipidemia. Arq. Bras. Cardiol. 109 (5), 404\u2013409 (2017).","journal-title":"Arq. Bras. Cardiol."},{"issue":"5","key":"56344_CR9","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1158\/2326-6066.CIR-13-0119","volume":"1","author":"T Marichal","year":"2013","unstructured":"Marichal, T., Tsai, M. & Galli, S. J. Mast Cells: Potential Positive and Negative Roles in Tumor Biology. Cancer Immunol. Res. 1 (5), 269\u2013279 (2013).","journal-title":"Cancer Immunol. Res."},{"issue":"21","key":"56344_CR10","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1111\/1759-7714.14654","volume":"13","author":"V Longo","year":"2022","unstructured":"Longo, V. et al. Controversial role of mast cells in NSCLC tumor progression and angiogenesis. Thorac. Cancer. 13 (21), 2929\u20132934 (2022).","journal-title":"Thorac. Cancer"},{"key":"56344_CR11","doi-asserted-by":"crossref","unstructured":"Jackson, C. W. et al. Mast Cells in and Their Cellular Interactions Within the Tumor Environment. In Rezaei, N. (Ed.) Handbook of Cancer and Immunology. 1\u201328 (Springer, 2025).","DOI":"10.1007\/978-3-030-80962-1_21-2"},{"key":"56344_CR12","doi-asserted-by":"publisher","first-page":"1209056","DOI":"10.3389\/fimmu.2023.1209056","volume":"14","author":"X Liu","year":"2023","unstructured":"Liu, X. et al. Mast cells in colorectal cancer tumour progression, angiogenesis, and lymphangiogenesis. Front. Immunol. 14, 1209056 (2023).","journal-title":"Front. Immunol."},{"issue":"3","key":"56344_CR13","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s12016-019-08753-w","volume":"58","author":"DEA Komi","year":"2020","unstructured":"Komi, D. E. A. & Redegeld, F. A. Role of Mast Cells in Shaping the Tumor Microenvironment. Clin. Rev. Allergy Immunol. 58 (3), 313\u2013325 (2020).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"56344_CR14","doi-asserted-by":"publisher","first-page":"176103","DOI":"10.1016\/j.ejphar.2023.176103","volume":"960","author":"X Guo","year":"2023","unstructured":"Guo, X. et al. Role of mast cells activation in the tumor immune microenvironment and immunotherapy of cancers. Eur. J. Pharmacol. 960, 176103 (2023).","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"56344_CR15","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.molimm.2012.01.009","volume":"50","author":"H Wensman","year":"2012","unstructured":"Wensman, H. et al. Tumor-mast cell interactions: induction of pro-tumorigenic genes and anti-tumorigenic 4-1BB in MCs in response to Lewis Lung Carcinoma. Mol. Immunol. 50 (4), 210\u2013219 (2012).","journal-title":"Mol. Immunol."},{"issue":"4","key":"56344_CR16","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.celrep.2014.04.041","volume":"7","author":"C Libert","year":"2014","unstructured":"Libert, C. & Dejager, L. How Steroids Steer T Cells. Cell. Rep. 7 (4), 938\u2013939 (2014).","journal-title":"Cell. Rep."},{"issue":"8","key":"56344_CR17","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/0960-0760(92)90307-5","volume":"43","author":"I Hanukoglu","year":"1992","unstructured":"Hanukoglu, I. Steroidogenic enzymes - structure, function, and role in regulation of steroid-hormone biosynthesis. J. Steroid Biochem. Mol. Biol. 43 (8), 779\u2013804 (1992).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"1","key":"56344_CR18","doi-asserted-by":"publisher","first-page":"E11","DOI":"10.1152\/ajpendo.00100.2011","volume":"301","author":"MD Taves","year":"2011","unstructured":"Taves, M. D., Gomez-Sanchez, C. E. & Soma, K. K. Extra-adrenal glucocorticoids and mineralocorticoids: evidence for local synthesis, regulation, and function. Am. J. Physiol. Endocrinol. Metab. 301 (1), E11\u201324 (2011).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"56344_CR19","first-page":"0","volume-title":"Hormones, Genes, And Cancer","author":"FZ Stanczyk","year":"2003","unstructured":"Stanczyk, F. Z. Biosynthesis, Transport, and Metabolism of Steroid Hormones. In Hormones, Genes, And Cancer 0-[object Object] (Oxford University Press, 2003)."},{"issue":"3","key":"56344_CR20","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ygcen.2008.03.025","volume":"157","author":"KL Schmidt","year":"2008","unstructured":"Schmidt, K. L. et al. Neurosteroids, immunosteroids, and the Balkanization of endocrinology. Gen. Comp. Endocrinol. 157 (3), 266\u2013274 (2008).","journal-title":"Gen. Comp. Endocrinol."},{"issue":"3","key":"56344_CR21","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41435-020-0096-6","volume":"21","author":"RM Slominski","year":"2020","unstructured":"Slominski, R. M. et al. Extra-adrenal glucocorticoid biosynthesis: implications for autoimmune and inflammatory disorders. Genes Immun. 21 (3), 150\u2013168 (2020).","journal-title":"Genes Immun."},{"issue":"3","key":"56344_CR22","doi-asserted-by":"publisher","first-page":"113936","DOI":"10.1016\/j.celrep.2024.113936","volume":"43","author":"LF Sandor","year":"2024","unstructured":"Sandor, L. F. et al. De novo steroidogenesis in tumor cells drives bone metastasis and osteoclastogenesis. Cell. Rep. 43 (3), 113936 (2024).","journal-title":"Cell. Rep."},{"issue":"3","key":"56344_CR23","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.ccell.2023.01.009","volume":"41","author":"EN Arner","year":"2023","unstructured":"Arner, E. N. & Rathmell, J. C. Metabolic programming and immune suppression in the tumor microenvironment. Cancer Cell. 41 (3), 421\u2013433 (2023).","journal-title":"Cancer Cell."},{"issue":"9","key":"56344_CR24","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/s41556-019-0373-7","volume":"21","author":"IS Kim","year":"2019","unstructured":"Kim, I. S. et al. Immuno-subtyping of breast cancer reveals distinct myeloid cell profiles and immunotherapy resistance mechanisms. Nat. Cell Biol. 21 (9), 1113\u20131126 (2019).","journal-title":"Nat. Cell Biol."},{"issue":"26","key":"56344_CR25","doi-asserted-by":"publisher","first-page":"6930","DOI":"10.1182\/blood-2011-03-343962","volume":"118","author":"JN Lilla","year":"2011","unstructured":"Lilla, J. N. et al. Reduced mast cell and basophil numbers and function in Cpa3-Cre; Mcl-1\u00a0fl\/fl mice. Blood 118 (26), 6930\u20136938 (2011).","journal-title":"Blood"},{"issue":"1","key":"56344_CR26","doi-asserted-by":"publisher","first-page":"3588","DOI":"10.1038\/s41467-020-17339-6","volume":"11","author":"B Mahata","year":"2020","unstructured":"Mahata, B. et al. Tumors induce de novo steroid biosynthesis in T cells to evade immunity. Nat. Commun. 11 (1), 3588 (2020).","journal-title":"Nat. Commun."},{"key":"56344_CR27","doi-asserted-by":"publisher","first-page":"801096","DOI":"10.3389\/fimmu.2021.801096","volume":"12","author":"MA Alim","year":"2021","unstructured":"Alim, M. A. et al. Pleckstrin Levels Are Increased in Patients with Chronic Periodontitis and Regulated via the MAP Kinase-p38\u03b1 Signaling Pathway in Gingival Fibroblasts. Front. Immunol. 12, 801096 (2021).","journal-title":"Front. Immunol."},{"issue":"5","key":"56344_CR28","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1111\/j.1365-2133.2004.05966.x","volume":"150","author":"MA Grimbaldeston","year":"2004","unstructured":"Grimbaldeston, M. A. et al. Association between melanoma and dermal mast cell prevalence in sun-unexposed skin. Br. J. Dermatol. 150 (5), 895\u2013903 (2004).","journal-title":"Br. J. Dermatol."},{"issue":"5","key":"56344_CR29","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1046\/j.1365-2362.2003.01152.x","volume":"33","author":"D Ribatti","year":"2003","unstructured":"Ribatti, D. et al. Tumor vascularity and tryptase-positive mast cells correlate with a poor prognosis in melanoma. Eur. J. Clin. Invest. 33 (5), 420\u2013425 (2003).","journal-title":"Eur. J. Clin. Invest."},{"issue":"5","key":"56344_CR30","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/S0959-8049(02)00150-8","volume":"39","author":"D Ribatti","year":"2003","unstructured":"Ribatti, D. et al. Neovascularisation, expression of fibroblast growth factor-2, and mast cells with tryptase activity increase simultaneously with pathological progression in human malignant melanoma. Eur. J. Cancer. 39 (5), 666\u2013674 (2003).","journal-title":"Eur. J. Cancer"},{"issue":"8","key":"56344_CR31","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1053\/hupa.2000.16658","volume":"31","author":"R T\u00f3th-Jakatics","year":"2000","unstructured":"T\u00f3th-Jakatics, R. et al. Cutaneous malignant melanoma: correlation between neovascularization and peritumor accumulation of mast cells overexpressing vascular endothelial growth factor. Hum. Pathol. 31 (8), 955\u2013960 (2000).","journal-title":"Hum. Pathol."},{"issue":"3","key":"56344_CR32","first-page":"139","volume":"62","author":"G Dyduch","year":"2011","unstructured":"Dyduch, G., Oko\u0144, K. & Pescarini, E. Mast cells in melanocytic skin lesions. An immunohistochemical and quantitative study. Pol. J. Pathol. 62 (3), 139\u2013144 (2011).","journal-title":"Pol. J. Pathol."},{"key":"56344_CR33","doi-asserted-by":"publisher","first-page":"794974","DOI":"10.3389\/fimmu.2022.794974","volume":"13","author":"T Annese","year":"2022","unstructured":"Annese, T. et al. Autocrine\/Paracrine Loop Between SCF(+)\/c-Kit(+) Mast Cells Promotes Cutaneous Melanoma Progression. Front. Immunol. 13, 794974 (2022).","journal-title":"Front. Immunol."},{"issue":"42","key":"56344_CR34","doi-asserted-by":"publisher","first-page":"68990","DOI":"10.18632\/oncotarget.11837","volume":"7","author":"H \u00d6hrvik","year":"2016","unstructured":"\u00d6hrvik, H. et al. Mast cells promote melanoma colonization of lungs. Oncotarget 7 (42), 68990\u201369001 (2016).","journal-title":"Oncotarget"},{"issue":"2","key":"56344_CR35","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/imm.13604","volume":"168","author":"A Benito-Martin","year":"2023","unstructured":"Benito-Martin, A. et al. Mast cells impair melanoma cell homing and metastasis by inhibiting HMGA1 secretion. Immunology 168 (2), 362\u2013373 (2023).","journal-title":"Immunology"},{"issue":"15","key":"56344_CR36","doi-asserted-by":"publisher","first-page":"25066","DOI":"10.18632\/oncotarget.15339","volume":"8","author":"M Grujic","year":"2017","unstructured":"Grujic, M. et al. The combined action of mast cell chymase, tryptase and carboxypeptidase A3 protects against melanoma colonization of the lung. Oncotarget 8 (15), 25066\u201325079 (2017).","journal-title":"Oncotarget"},{"key":"56344_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00424","volume":"8","author":"G Varricchi","year":"2017","unstructured":"Varricchi, G. et al. Are mast cells masters in cancer?. Front. Immunol. 8, 424 (2017).","journal-title":"Front. Immunol."},{"issue":"1","key":"56344_CR38","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.molimm.2014.02.020","volume":"63","author":"SA Oldford","year":"2015","unstructured":"Oldford, S. A. & Marshall, J. S. Mast cells as targets for immunotherapy of solid tumors. Mol. Immunol. 63 (1), 113\u2013124 (2015).","journal-title":"Mol. Immunol."},{"issue":"24","key":"56344_CR39","doi-asserted-by":"publisher","first-page":"4981","DOI":"10.1182\/blood-2010-01-257287","volume":"115","author":"G Pejler","year":"2010","unstructured":"Pejler, G. et al. Mast cell proteases: multifaceted regulators of inflammatory disease. Blood 115 (24), 4981\u20134990 (2010).","journal-title":"Blood"},{"key":"56344_CR40","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0065-2776(07)95006-3","volume":"95","author":"G Pejler","year":"2007","unstructured":"Pejler, G. et al. Mast cell proteases. Adv. Immunol. 95, 167\u2013255 (2007).","journal-title":"Adv. Immunol."},{"issue":"1\u20132","key":"56344_CR41","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0022-1759(03)00265-5","volume":"281","author":"MR Betts","year":"2003","unstructured":"Betts, M. R. et al. Sensitive and viable identification of antigen-specific CD8\u2009+\u2009T cells by a flow cytometric assay for degranulation. J. Immunol. Methods. 281 (1\u20132), 65\u201378 (2003).","journal-title":"J. Immunol. Methods"},{"key":"56344_CR42","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/978-1-4939-8885-3_7","volume":"1884","author":"S Lorenzo-Herrero","year":"2019","unstructured":"Lorenzo-Herrero, S. et al. CD107a Degranulation Assay to Evaluate Immune Cell Antitumor Activity. Methods Mol. Biol. 1884, 119\u2013130 (2019).","journal-title":"Methods Mol. Biol."},{"key":"56344_CR43","first-page":"497","volume-title":"Methods in Cell Biology","author":"MR Betts","year":"2004","unstructured":"Betts, M. R. & Koup, R. A. Detection of T-Cell Degranulation: CD107a and b. In Methods in Cell Biology 497\u2013512 (Academic Press, 2004)."},{"issue":"3","key":"56344_CR44","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/S1470-2045(18)30078-0","volume":"19","author":"JL McQuade","year":"2018","unstructured":"McQuade, J. L. et al. Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis. Lancet Oncol. 19 (3), 310\u2013322 (2018).","journal-title":"Lancet Oncol."},{"issue":"4","key":"56344_CR45","first-page":"570","volume":"169","author":"MD Buck","year":"2017","unstructured":"Buck, M. D. et al. Metabolic Instruction Immun. Cell., 169(4): 570\u2013586. (2017).","journal-title":"Metabolic Instruction Immun. Cell."},{"issue":"Pt A","key":"56344_CR46","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jsbmb.2013.10.012","volume":"144","author":"AT Slominski","year":"2014","unstructured":"Slominski, A. T. et al. The role of CYP11A1 in the production of vitamin D metabolites and their role in the regulation of epidermal functions. J. Steroid Biochem. Mol. Biol. 144 (Pt A), 28\u201339 (2014).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"10","key":"56344_CR47","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1016\/j.jid.2024.04.022","volume":"144","author":"AT Slominski","year":"2024","unstructured":"Slominski, A. T. et al. Biological Effects of CYP11A1-Derived Vitamin D and Lumisterol Metabolites in the Skin. J. Invest. Dermatol. 144 (10), 2145\u20132161 (2024).","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"56344_CR48","doi-asserted-by":"publisher","first-page":"4360","DOI":"10.1038\/s41467-021-24537-3","volume":"12","author":"S Prekovic","year":"2021","unstructured":"Prekovic, S. et al. Glucocorticoid receptor triggers a reversible drug-tolerant dormancy state with acquired therapeutic vulnerabilities in lung cancer. Nat. Commun. 12 (1), 4360 (2021).","journal-title":"Nat. Commun."},{"issue":"1","key":"56344_CR49","doi-asserted-by":"publisher","first-page":"2286820","DOI":"10.1080\/2162402X.2023.2286820","volume":"13","author":"H Poinot","year":"2024","unstructured":"Poinot, H. et al. Activation of endogenous glucocorticoids by HSD11B1 inhibits the antitumor immune response in renal cancer. OncoImmunology 13 (1), 2286820 (2024).","journal-title":"OncoImmunology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56344-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56344-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56344-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T16:02:30Z","timestamp":1780416150000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56344-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["56344"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-56344-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]},"assertion":[{"value":"9 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16983"}}